Background: Patients with epilepsy develope a wide range of medical and neurologic disorders, compared with the general population. The association between epilepsy and atherosclerosis is not clearly defined. Several studies claims that epileptic patients may have the risk to develop atherosclerosis. Methods: This study included 40 adult epileptic and 40 control subjects. For all, Common carotid artery intima media thickness (CA-IMT), fasting lipid profile, serum uric acid (SUA), C -reactive protein (CRP) and glutathione peroxidase (GPX), were assessed. Results: Total cholesterol (TC) ,low density lipoproteins (LDL), Total Triglycerides (TG) ,CRP, GPX were significantly higher in patients compared to control. CA-IMT was significantly higher in epileptic patients treated with antiepileptic drugs (AEDS) compared to control group. The longer the duration of AEDs the thicker was the CA-IMT. Conclusions: Our results heightened atherosclerotic risk in patients with epilepsy on AEDS.
INTRODUCTION
pilepsy is one of the most common serious neurological disorders which affect about 50 million people worldwide each year .
[1] Antiepileptic drugs (AEDs) may differentially influence atherosclerotic risk in patients with epilepsy through alteration of vascular markers.
In addition chronic exposure of AEDs may alter the oxidative/antioxidative balance that results in oxidative stress which further damages endothelial cells and contributes to the atherosclerotic process.
[3] So, epilepsy and carotid atherosclerosis appear to share many risk factors. These shared risk factors include, weight gain and obesity, insulin resistance (IR), lipid abnormalities, high levels of inflammatory and oxidative stresses and increased CA-IMT.
[2]
,
[4], [5] . CA-IMT as assessed by ultrasound is considered to be a surrogate measure of atherogenesis and has been strongly correlated with risk of both stroke and myocardial infarction 
AIM OF WORK
This study aimed to evaluate the CA-IMT in adult epileptic patients on antiepileptic drugs (AEDs) and its relation to oxidative stress and vascular risk biomarkers. . Fasting (at least 10 hours) venous blood samples (2 mL) of patients and control subjects were withdrawn sera were separated. They were kept frozen for the assay of serum levels of TC, TG, HDL-c, LDL-c, GPX, CRP and SUA. Autoanalyser by colometric method applied for triglycerides and cholesterol measurements.
PATIENTS AND METHODS
AutoZyme high-density lipoprotein (HDL) cholesterol regent used for HDL determination while LDL calculated by Freidwald formula: LDL = TC -(HDL × 0.2 Triglycerides). Glutathion peroxidase was determined spectrophotometrically according to the method described Hefeman et al.
[8] A radiology specialist performed B mode ultrasound examinations with using high resolution 7.5 MHz transducers (iU22 Philips ultrasound) on subjects in the supine position. Images of wall thickness of common carotid artery IMT were recorded at both right and left common carotid arteries to assess the extent of atherosclerosis. Both the left and right common carotid arteries (CCAs) were scanned, The IMT, the interface between the lumen, intima ,media and adventitia, was measured using a computer software program. For each subject the mean IMT was calculated as the average of all mean IMT measurements. Table 1 showed the demographic and clinical characteristics of patients and controls.. The mean systolic and diastolic blood pressure, BMI and fasting blood glucose of patients showed no significant difference compared with control subjects. Most of patients 75% (n=30) had primary generalized; while 25% (n = 10) had focal epilepsies. About 42.5% of patients were on polytherapy while 57.5% were on monotherapy with 43.4% on carbamazepine (CBZ) and 65.6% on valproate (VPA). 
RESULTS

DISCUSSION
As atherosclerosis is a potentially preventable disease, early understanding of its risk factors in young adults is important to prevent its development in later life. our study revealed alteration of various vascular risk factors including lipid profile, CRP, GPX and uric acid in young adult patients with epilepsy on traditional AEDs and their contribution to increased CA-IMT, a strong potential marker of early or subclinical atherosclerosis. Dyslipidemia has long been known to be an important risk factor for atherosclerosis [9] .We demonstrated that alteration of lipid profile is common among patients with epilepsy in agreement with others [10, 11, 12] . The increased levels of TC, LDL-c and TG were significantly higher in our patients than control group. This investigation is in coincidence with Tomoum et al. [13] and Kumar et al. [14] and but is against Erdemir et al. and Keenan et al. [15] , [16] who did not observe any differences regarding serum lipid profiles between epileptic and healthy children. This modification of lipid profile is particularly significant among CBZ and polytherapy group than VPA group. Similar results were reported by other studies [17, 18, 19, 20] . In this respect, it has been reported that chronic treatment with AEDs may compete with cholesterol in the utilization of hepatic microsomal enzymes P-450 system leading to reduction in the transformation of cholesterol to bile acids resulting in increase in serum cholesterol level [21] while Hsieh et al. [22] reported that enzyme-inducing AEDs like CBZ increase the activity of the hepatic cytochrome P450 system, which is involved in synthesis of serum cholesterol, though direct studies are needed, our findings are wholly consistent with this hypothesis. The increased LDL-c levels in patients on AEDs may be an indirect effect of decreased thyroid hormone level which is a common side effect of AEDS [23] CRP levels were significantly higher in our patients in comparison to control. This result goes hand in hand with many studies [30] reported reduction of CRP level in patients treated with VPA, in agreement with Mintzer [31] who also reported that patients who were switched from inducing to non-inducing agents had marked reductions in CRP. This suggests that CYP450 induction may be responsible for CRP level increase [32] .
Regarding oxidative stress biomarkers, uric acid levels were found to be slightly higher in our cases with no significant difference between cases and control. This finding is in parallelism with Menon et al. [11] however our results were in disagreement with Krause et al. [33] who revealed significantly lower serum concentrations of uric acid in epileptic patients compared to a group of normal controls. Uric acid was significantly higher in patients with VPA monotherapy than both the CBZ group and polytherapy group. Similar findings were reported by Tan et al. [ 
25]
Elevation of uric acid level in VPA group can be attributed to its altered renal secretion by VPA [34] . As such, long-term therapy with VPA in patients with epilepsy may increase the levels of uric acid that may contribute to atherosclerotic risk through inducing endothelial dysfuction and altering nitric oxide secretion. Krause et al. [33] reported that in patients taking enzyme-inducing drugs, uric acid levels were found to be lower than in those under VPA treatment and postulated that acceleration of protein synthesis, due to enzyme-induction may lead to lowering uric acid level and reported the possible use of this finding in the treatment of hyperuricemia. Glutathione peroxidase in our patients was significantly higher than those in the control group. This is in agreement with several studies [11, 35, 36, 37] . We suggest that GPX upregulation, in patients with epilepsy receiving AEDS, might be a consequence of induced GPX synthesis in the liver as a compensatory mechanism for decreased glutathione levels in the same group of patients. We also observed slightly higher GPX level in VPA group and poly-therapy Ali M.; et al… -67-group than CBZ group although the difference was not significant. This is in agreement with others [35, 36, 38] . Hamed et al. [5] demonstrated marked reduction in GPX levels among the untreated patients and elevated to normal levels with AED medications. It even increased above normal limits with VPA therapy (mono-and polytherapy) which is consistent with our results. Alterations in the antioxidant system induced by AED therapy can be explained by the metabolism of AED into reactive epoxide intermediates, which can induce structural and functional impairments [39] . Therefore, we suggest that the risk of atherosclerosis in CBZ group may be related to inflammatory mechanisms manifested by increased CRP and in the VPA group may be associated with oxidative mechanisms through affection of the antioxidant enzymes This study provides evidence of the high risk to develop atherosclerosis among patients with epilepsy. We demonstrated significant increase in the CA-IMT in epileptic patients in comparison to healthy control. This result is in agreement with Mintzer [31] as well as Erdemir et al. [14] and Talaat et al . [40] .On the other hand our results disagree with Tomoum et al. [12] and Keenan et al. [15] who found no difference between epileptic patients and control regarding CA-IMT . This disagreement can be attributed to differences in sample size and methodology. Furthermore, we found that patients treated with CBZ and polythearapy demonstrated more increase in CIMT than those treated with VPA this in concordance with Hamed et al. [ 
5]
However, according to Belcastro et al. [41] VPA can also cause insulin resistance with hyperinsulinemia which may also lead to atherosclerosis as insulin increases the activity of the enzymes involved in cholesterol synthesis .On the contrary Mehrpour et al. [42] documented that in Iranian they did not find any difference between the patients with epilepsy treated with either VPA or CBZ. Based on correlation analysis, our results revealed that age, BMI, systolic , diastolic blood pressure were 
